These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6356059)

  • 81. Editorial: Antimicrobial treatment of chronic bronchitis.
    Lancet; 1975 Mar; 1(7905):505-6. PubMed ID: 46968
    [No Abstract]   [Full Text] [Related]  

  • 82. Antibiotic susceptibility of type b Haemophilus influenzae and Streptococcus pneumoniae, and antibiotic concentration in cerebrospinal fluid.
    Fujita K; Zhang DH; Sakata H; Murono K; Kakehashi H; Yoshioka H
    Acta Paediatr Jpn; 1990 Apr; 32(2):132-8. PubMed ID: 2116062
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [3-year surveillance of in vitro sensitivity of Haemophilus influenzae causing pediatric infections].
    Reyes L; Prado V
    Rev Chil Pediatr; 1986; 57(2):128-33. PubMed ID: 3494276
    [No Abstract]   [Full Text] [Related]  

  • 84. The selection of antibiotics for the initial treatment of bacterial meningitis.
    Lovell S; Dugdale AE
    Med J Aust; 1973 Mar; 1(11):529-32. PubMed ID: 4540652
    [No Abstract]   [Full Text] [Related]  

  • 85. Plasmid transfer in Haemophilus influenzae.
    Stuy JH
    J Bacteriol; 1979 Aug; 139(2):520-9. PubMed ID: 313393
    [TBL] [Abstract][Full Text] [Related]  

  • 86. In vitro development of rifampin resistance in clinical isolates of Haemophilus influenzae type b.
    Yogev R; Melick C; Glogowski W
    Antimicrob Agents Chemother; 1982 Mar; 21(3):387-9. PubMed ID: 6980621
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Effect of antibiotics on adherence of Haemophilus influenzae type b.
    Gilsdorf JR; Jesperson JM
    Antimicrob Agents Chemother; 1986 Sep; 30(3):370-4. PubMed ID: 3490826
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Mutation frequency of Haemophilus influenzae to rifampin resistance.
    Mendelman PM; Roberts MC; Smith AL
    Antimicrob Agents Chemother; 1982 Sep; 22(3):531-3. PubMed ID: 6982682
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Discovery and Characterization of a Nitroreductase Capable of Conferring Bacterial Resistance to Chloramphenicol.
    Crofts TS; Sontha P; King AO; Wang B; Biddy BA; Zanolli N; Gaumnitz J; Dantas G
    Cell Chem Biol; 2019 Apr; 26(4):559-570.e6. PubMed ID: 30799223
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Emergence of rifampin-resistant Haemophilus influenzae.
    Nicolle LE; Postl B; Kotelewetz E; Albritton W; Harding GK; Bourgault AM; Ronald AR
    Antimicrob Agents Chemother; 1982 Mar; 21(3):498-500. PubMed ID: 6980623
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Susceptibility of Haemophilus influenzae type b to rifampin and sulfisoxazole.
    Bannatyne RM; Cheung R
    Antimicrob Agents Chemother; 1978 Jun; 13(6):969-70. PubMed ID: 307940
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Comparative inhibition of Haemophilus influenzae by eight antibiotics.
    Khan W; Ross S; Zaremba EA
    Antimicrob Agents Chemother (Bethesda); 1966; 6():393-6. PubMed ID: 5299288
    [No Abstract]   [Full Text] [Related]  

  • 93. Investigating the promiscuity of the chloramphenicol nitroreductase from Haemophilus influenzae towards the reduction of 4-nitrobenzene derivatives.
    Green KD; Fosso MY; Mayhoub AS; Garneau-Tsodikova S
    Bioorg Med Chem Lett; 2019 May; 29(9):1127-1132. PubMed ID: 30826292
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Meningitis due to beta lactamase producing type 'b' Hemophilus influenzae resistant to chloramphenicol in India--a case report.
    Ayyagari A; Kaur P; Sachdeva S; Kumar L
    Indian J Pediatr; 1984; 51(412):615-7. PubMed ID: 6336084
    [No Abstract]   [Full Text] [Related]  

  • 95. Pharmacokinetics and therapeutic efficacy of imipenem, ceftazidime, and ceftriaxone in experimental meningitis due to an ampicillin- and chloramphenicol-resistant strain of Haemophilus influenzae type b.
    Sakata Y; McCracken GH; Thomas ML; Olsen KD
    Antimicrob Agents Chemother; 1984 Jan; 25(1):29-32. PubMed ID: 6322679
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Treatment of bacterial meningitis.
    Schaad UB
    Eur J Clin Microbiol; 1986 Oct; 5(5):492-7. PubMed ID: 3536497
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Ampicillin disk diffusion susceptibility testing of Haemophilus influenzae.
    Doern GV; Daum GS; Tubert TA
    J Clin Microbiol; 1987 Sep; 25(9):1675-8. PubMed ID: 3498738
    [TBL] [Abstract][Full Text] [Related]  

  • 98. In vitro activity of LY163892 against pathogens isolated from pediatric patients.
    Wenman WM; Kibsey PC; Gratton CA; Knight VE
    Eur J Clin Microbiol Infect Dis; 1988 Jun; 7(3):434-6. PubMed ID: 3137056
    [No Abstract]   [Full Text] [Related]  

  • 99. Cerebrospinal fluid shunt infections by unencapsulated Haemophilus influenzae.
    Hellbusch LC; Penn RG
    Childs Nerv Syst; 1989 Oct; 5(5):315-7. PubMed ID: 2805003
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Antimicrobial susceptibility patterns of Haemophilus isolates from children in eleven developing nations. BOSTID Haemophilus Susceptibility Study Group.
    Weinberg GA; Spitzer ED; Murray PR; Ghafoor A; Montgomery J; Tupasi TE; Granoff DM
    Bull World Health Organ; 1990; 68(2):179-84. PubMed ID: 2364476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.